Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2003-12-19
2009-06-16
Jiang, Dong (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387300, C530S388150, C530S391300
Reexamination Certificate
active
07547766
ABSTRACT:
The invention provides isolated nucleic acids encoding a variety of proteins having diagnostic, preventive, therapeutic, and other uses. These nucleic and proteins are useful for diagnosis, prevention, and therapy of a number of human and other animal disorders. The invention also provides antisense nucleic acid molecules, expression vectors containing the nucleic acid molecules of the invention, host cells into which the expression vectors have been introduced, and non-human transgenic animals in which a nucleic acid molecule of the invention has been introduced or disrupted. The invention still further provides isolated polypeptides, fusion polypeptides, antigenic peptides and antibodies. Diagnostic, screening, and therapeutic methods using compositions of the invention are also provided. The nucleic acids and polypeptides of the present invention are useful as modulating agents in regulating a variety of cellular processes.
REFERENCES:
patent: 3654090 (1972-04-01), Hermanus et al.
patent: 5807726 (1998-09-01), Blanchard et al.
patent: 0911399 (1999-04-01), None
patent: 95/14772 (1995-01-01), None
patent: WO 96/34873 (1996-11-01), None
patent: WO 98/45436 (1998-10-01), None
patent: WO 99/06550 (1999-02-01), None
patent: WO 00/06698 (2000-02-01), None
Sequence search results: sequence alignment between SEQ ID No. 417 of the present application and SEQ ID No. 3 of US5,807,726.
Sequence search results: sequence alignment between SEQ ID No. 417 of the present application and sequence in Figure 4 of Anderson et al. J. Biol. Chem., 1991, 266: 22479-84.
Nakagawa et al. Cloning of rat lysosomal acid lipase cDNA and identification of the mutation in the rat model Wolman's disease. J. Lipid Res., 1995, 36:2212-2218.
Campbell, A. Laboratory Techniques in Biochemistry And Molecular Biology, vol. 13, Chapter 1, pp. 1-33, 1984.
Sandhu, J.S. Protein engineering of antibodies. 1992, Critical Reviews in Biotech., 12(5/6): 437-462.
E. Benjamini et al., “Antigenicity”. Immunology, A Short Course, 2nd ed., 1992 (John Wiley & Sons, Inc.), p. 40.
S. Vukicevic et al. Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7). 1996. Proc. Natl. Acad. Sci. USA, 93: 9021-26.
J. Skolnick et al. From genes to protein structure and function: novel applications of computational approaches in the genomic era. 2000. Trends in Biotechnology, 18(1): 34-39.
S. E. Brenner. Errors in genome annotation. 1999. Trends in Genetics, 15(4): 132-33.
R.A. Anderson et al. Cloning and expression of cDNA encoding human lysosomal acid lipase/cholesteryl ester hydrolase. 1991. J. Biol. Chem., 266(33): 22479-84.
H. Du et al. Locus HSU08464, Jun. 23, 1994. Accessed Aug. 27, 2001 (see attached computer printout).
Elsbach, 1998, Journal of Leukocyte Biology, 64:14-18.
Barnes Thomas M.
Sharp John D.
Jiang Dong
Millennium Pharmaceuticals Inc.
LandOfFree
Anti-tango294 antibodies and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-tango294 antibodies and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-tango294 antibodies and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4065332